HCV Inhibitors
    1.
    发明申请
    HCV Inhibitors 有权
    HCV抑制剂

    公开(公告)号:US20070054864A1

    公开(公告)日:2007-03-08

    申请号:US11478337

    申请日:2006-06-28

    IPC分类号: A61K38/05 C07K5/06

    CPC分类号: A61K38/05 C07K5/06034

    摘要: The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

    摘要翻译: 本发明涉及作为抗病毒剂的化合物。 具体地说,本发明的化合物抑制HCV的复制,因此可用于治疗丙型肝炎感染。 本发明还涉及包含这些化合物的药物组合物及其制备方法。

    Silinane compounds as cysteine protease inhibitors
    2.
    发明申请
    Silinane compounds as cysteine protease inhibitors 审中-公开
    硅烷化合物作为半胱氨酸蛋白酶抑制剂

    公开(公告)号:US20070088001A1

    公开(公告)日:2007-04-19

    申请号:US10587867

    申请日:2005-01-31

    IPC分类号: A61K31/695 C07F7/08

    CPC分类号: C07F7/0812 C07F7/081

    摘要: The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them. The present invention is also directed to the use of these inhibitors in combination with a therapy that causes a deleterious immune response in patients receiving the therapy.

    摘要翻译: 本发明涉及半胱氨酸蛋白酶,特别是组织蛋白酶B,K,L,F和S的抑制剂的化合物,因此可用于治疗由这些蛋白酶介导的疾病。 本发明还涉及包含这些化合物的药物组合物及其制备方法。 本发明还涉及这些抑制剂与在接受治疗的患者中引起有害免疫应答的疗法的组合的用途。

    Alpha ketoamide compounds as cysteine protease inhibitors
    4.
    发明申请
    Alpha ketoamide compounds as cysteine protease inhibitors 有权
    α-酮酰胺化合物作为半胱氨酸蛋白酶抑制剂

    公开(公告)号:US20070021353A1

    公开(公告)日:2007-01-25

    申请号:US11384023

    申请日:2006-03-17

    IPC分类号: A61K38/04 C07C237/02

    摘要: The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

    摘要翻译: 本发明涉及半胱氨酸蛋白酶,特别是组织蛋白酶B,K,L,F和S的抑制剂的化合物,因此可用于治疗由这些蛋白酶介导的疾病。 本发明涉及包含这些化合物的药物组合物及其制备方法。